Public Interest (Healthcare) Concerns in Indian Patent Regim

Explore Public Interest Healthcare Concerns Under the Indian Patent Regime with our comprehensive course. This in-depth exploration examines the crucial relationship between public health and patent law in India, focusing on healthcare, pharmaceutical patents, and access to medicines.

Discover how Indian patent regulations impact the availability of lifesaving drugs versus lifestyle drugs, and understand the historical evolution of India's patent system designed to address public health needs.

We'll dissect Chapter XVI of the Indian Patents Act, analyzing its significance in ensuring patents benefit society, particularly in healthcare. Learn about landmark cases like the Novartis case and the importance of Section 83 of the Patents Act in balancing patent rights with public interest.

Understand the controversial issue of patent evergreening and its effect on affordable healthcare. We'll also delve into Section 84(1) of the Patents Act and the crucial mechanism of compulsory licensing for ensuring access to essential medicines.

Gain insights from detailed case studies, including the Lipitor case and its impact on generic drug availability in India. We'll also analyze the Omeprazole case and its relevance to healthcare access during emergencies, especially in light of the COVID-19 pandemic.

Learn about the general principles governing compulsory licenses in the healthcare sector, examining the Natco vs. Bayer case and its implications for access to life-saving drugs.

Finally, we'll explore Section 92A of the Patents Act, detailing the process for revocation of patents in public interest for the betterment of public health.

This course, led by experienced professionals in law and healthcare, provides a comprehensive understanding of the complexities surrounding public interest healthcare and the Indian patent regime. Enroll now to gain valuable insights and become well-versed in this critical area.